190 related articles for article (PubMed ID: 37662519)
1. Personalised decision making to predict absolute metastatic risk in cutaneous squamous cell carcinoma: development and validation of a clinico-pathological model.
Rentroia-Pacheco B; Tokez S; Bramer EM; Venables ZC; van de Werken HJG; Bellomo D; van Klaveren D; Mooyaart AL; Hollestein LM; Wakkee M
EClinicalMedicine; 2023 Sep; 63():102150. PubMed ID: 37662519
[TBL] [Abstract][Full Text] [Related]
2. Validating 4 Staging Systems for Cutaneous Squamous Cell Carcinoma Using Population-Based Data: A Nested Case-Control Study.
Roscher I; Falk RS; Vos L; Clausen OPF; Helsing P; Gjersvik P; Robsahm TE
JAMA Dermatol; 2018 Apr; 154(4):428-434. PubMed ID: 29516080
[TBL] [Abstract][Full Text] [Related]
3. Validation of four cutaneous squamous cell carcinoma staging systems using nationwide data.
Venables ZC; Tokez S; Hollestein LM; Mooyaart AL; van den Bos RR; Rous B; Leigh IM; Nijsten T; Wakkee M
Br J Dermatol; 2022 May; 186(5):835-842. PubMed ID: 34862598
[TBL] [Abstract][Full Text] [Related]
4. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention.
Stratigos AJ; Garbe C; Dessinioti C; Lebbe C; Bataille V; Bastholt L; Dreno B; Fargnoli MC; Forsea AM; Frenard C; Harwood CΑ; Hauschild A; Hoeller C; Kandolf-Sekulovic L; Kaufmann R; Kelleners-Smeets NW; Malvehy J; Del Marmol V; Middleton MR; Moreno-Ramirez D; Pellecani G; Peris K; Saiag P; van den Beuken-van Everdingen MHJ; Vieira R; Zalaudek I; Eggermont AMM; Grob JJ;
Eur J Cancer; 2020 Mar; 128():60-82. PubMed ID: 32113941
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous squamous cell carcinoma staging may influence management in users: A survey study.
Patel VA; McCullum C; Sparks AD; Schmults CD; Arron ST; Jambusaria-Pahlajani A
Cancer Med; 2022 Jan; 11(1):94-103. PubMed ID: 34796670
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiling for metastatic risk in head and neck cutaneous squamous cell carcinoma.
Arron ST; Wysong A; Hall MA; Bailey CN; Covington KR; Kurley SJ; Goldberg MS; Kasprzak JM; Somani AK; Ibrahim SF; Brodland DG; Cleaver NJ; Maher IA; Xia Y; Koyfman SA; Newman JG
Laryngoscope Investig Otolaryngol; 2022 Feb; 7(1):135-144. PubMed ID: 35155791
[TBL] [Abstract][Full Text] [Related]
7. Implications of Satellitosis or In-transit Metastasis in Cutaneous Squamous Cell Carcinoma: A Prognostic Omission in Cancer Staging Systems.
Smile TD; Ruiz ES; Kus KJB; Murad F; Wei W; Xiong DD; Vidimos AT; Schmults CD; Koyfman SA
JAMA Dermatol; 2022 Apr; 158(4):390-394. PubMed ID: 35195668
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of Patients With Multiple Cutaneous Squamous Cell Carcinomas: A 10-Year Single-Institution Cohort Study.
Levine DE; Karia PS; Schmults CD
JAMA Dermatol; 2015 Nov; 151(11):1220-5. PubMed ID: 26177278
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for metastatic cutaneous squamous cell carcinoma: Refinement and replication based on 2 nationwide nested case-control studies.
Tokez S; Venables ZC; Hollestein LM; Qi H; Bramer EM; Rentroia-Pacheco B; van den Bos RR; Rous B; Leigh IM; Nijsten T; Mooyaart AL; Wakkee M
J Am Acad Dermatol; 2022 Jul; 87(1):64-71. PubMed ID: 35259451
[TBL] [Abstract][Full Text] [Related]
10. Stratification of Poor Outcomes for Cutaneous Squamous Cell Carcinoma in Immunosuppressed Patients Using the American Joint Committee on Cancer Eighth Edition and Brigham and Women's Hospital Staging Systems.
Blechman AB; Carucci JA; Stevenson ML
Dermatol Surg; 2019 Sep; 45(9):1117-1124. PubMed ID: 30640779
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the American Joint Committee on Cancer Seventh Edition and Brigham and Women's Hospital Cutaneous Squamous Cell Carcinoma Tumor Staging in Immunosuppressed Patients.
Gonzalez JL; Cunningham K; Silverman R; Madan E; Nguyen BM
Dermatol Surg; 2017 Jun; 43(6):784-791. PubMed ID: 28079640
[TBL] [Abstract][Full Text] [Related]
12. Comparing the eighth and the seventh editions of the American Joint Committee on Cancer staging system and the Brigham and Women's Hospital alternative staging system for cutaneous squamous cell carcinoma: Implications for clinical practice.
Cañueto J; Burguillo J; Moyano-Bueno D; Viñolas-Cuadros A; Conde-Ferreirós A; Corchete-Sánchez LA; Pérez-Losada J; Román-Curto C
J Am Acad Dermatol; 2019 Jan; 80(1):106-113.e2. PubMed ID: 30003984
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline.
Stratigos A; Garbe C; Lebbe C; Malvehy J; del Marmol V; Pehamberger H; Peris K; Becker JC; Zalaudek I; Saiag P; Middleton MR; Bastholt L; Testori A; Grob JJ; ; ;
Eur J Cancer; 2015 Sep; 51(14):1989-2007. PubMed ID: 26219687
[TBL] [Abstract][Full Text] [Related]
14. Impact of Gene Expression Profile Testing on the Management of Squamous Cell Carcinoma by Dermatologists.
Rebeca T; Giselle P; Litchman GH; Rigel DS
J Drugs Dermatol; 2019 Oct; 18(10):980-984. PubMed ID: 31584775
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes of high-risk cutaneous squamous cell carcinomas treated with Mohs surgery alone: An analysis of local recurrence, regional nodal metastases, progression-free survival, and disease-specific death.
Soleymani T; Brodland DG; Arzeno J; Sharon DJ; Zitelli JA
J Am Acad Dermatol; 2023 Jan; 88(1):109-117. PubMed ID: 35760236
[TBL] [Abstract][Full Text] [Related]
16. Incidence of Multiple vs First Cutaneous Squamous Cell Carcinoma on a Nationwide Scale and Estimation of Future Incidences of Cutaneous Squamous Cell Carcinoma.
Tokez S; Hollestein L; Louwman M; Nijsten T; Wakkee M
JAMA Dermatol; 2020 Dec; 156(12):1300-1306. PubMed ID: 33112377
[TBL] [Abstract][Full Text] [Related]
17. Risk factors and timing of subsequent cutaneous squamous cell carcinoma in patients with cutaneous squamous cell carcinoma: A retrospective cohort study.
Rodriguez M; Beal BT; Manmohan M; Simmons E; Varra V; Xiong D; Eversman A; Briskin IN; Knackstedt T; Vidimos AT
J Am Acad Dermatol; 2021 Mar; 84(3):719-724. PubMed ID: 32861709
[TBL] [Abstract][Full Text] [Related]
18. Risk Factors and Prognosis for Metastatic Cutaneous Squamous Cell Carcinoma: A Cohort Study.
Knuutila JS; Riihilä P; Kurki S; Nissinen L; Kähäri VM
Acta Derm Venereol; 2020 Sep; 100(16):adv00266. PubMed ID: 32930344
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous Squamous Cell Carcinoma: A Review of High-Risk and Metastatic Disease.
Burton KA; Ashack KA; Khachemoune A
Am J Clin Dermatol; 2016 Oct; 17(5):491-508. PubMed ID: 27358187
[TBL] [Abstract][Full Text] [Related]
20. European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment-Update 2023.
Stratigos AJ; Garbe C; Dessinioti C; Lebbe C; van Akkooi A; Bataille V; Bastholt L; Dreno B; Dummer R; Fargnoli MC; Forsea AM; Harwood CA; Hauschild A; Hoeller C; Kandolf-Sekulovic L; Kaufmann R; Kelleners-Smeets NW; Lallas A; Leiter U; Malvehy J; Del Marmol V; Moreno-Ramirez D; Pellacani G; Peris K; Saiag P; Tagliaferri L; Trakatelli M; Ioannides D; Vieira R; Zalaudek I; Arenberger P; Eggermont AMM; Röcken M; Grob JJ; Lorigan P;
Eur J Cancer; 2023 Nov; 193():113252. PubMed ID: 37708630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]